Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 2581 AL 2595

Complex movement disorders in SARS-CoV-2 infection induced acute disseminated encephalomyelitis

Ghosh R, Dubey S, Mandal A, Ray BK, Benito-León J.

J Neuroimmunol. 2021 Sep 15;358:577655. doi: 10.1016/j.jneuroim.2021.577655. Epub 2021 Jun 30.

The auditory startle response in relation to outcome in functional movement disorders

Dreissen YEM, Koelman JHTM, Tijssen MAJ.

Parkinsonism Relat Disord. 2021 Aug;89:113-117. doi: 10.1016/j.parkreldis.2021.07.012. Epub 2021 Jul 13.

Generalised myoclonus associated with COVID-19 infection

Ram A, Jeelani H, Kumar D, Patel H.

BMJ Case Rep. 2021 Jul 22;14(7):e243780. doi: 10.1136/bcr-2021-243780.

Myoclonus- A Review

Chandarana M, Saraf U, Divya KP, Krishnan S, Kishore A.

Ann Indian Acad Neurol. 2021 May-Jun;24(3):327-338. doi: 10.4103/aian.AIAN_1180_20. Epub 2021 May 21.

Socio-demographic characteristics and psychopathological assessment in a sample of 13 paediatric patients with functional neurological disorders: A preliminary report

Paleari V, Nisticò V, Nardocci N, Canevini MP, Priori A, Gambini O, Zorzi G, Demartini B.

Clin Child Psychol Psychiatry. 2022 Apr;27(2):492-503. doi: 10.1177/13591045211055084. Epub 2021 Nov 6.

Effectiveness of Botulinum Toxin A Injection in Managing Mobility-Related Outcomes in Adult Patients With Cerebral Palsy: Systematic Review

Andraweera ND, Andraweera PH, Lassi ZS, Kochiyil V.

Am J Phys Med Rehabil. 2021 Sep 1;100(9):851-857. doi: 10.1097/PHM.0000000000001653.

Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia - The SPASTOX Trial

Diniz de Lima F, Faber I, Servelhere KR, Bittar MFR, Martinez ARM, Piovesana LG, Martins MP, Martins CR Jr, Benaglia T, de Sá Carvalho B, Nucci A, França MC Jr.

Mov Disord. 2021 Jul;36(7):1654-1663. doi: 10.1002/mds.28523. Epub 2021 Feb 17.

Expanding the genotypic spectrum of PYCR2 and a common ancestry in Thai patients with hypomyelinating leukodystrophy 10

Manaspon C, Boonsimma P, Phokaew C, Theerapanon T, Sriwattanapong K, Porntaveetus T, Shotelersuk V.

Am J Med Genet A. 2021 Oct;185(10):3068-3073. doi: 10.1002/ajmg.a.62365. Epub 2021 May 26.

IncobotulinumtoxinA for the treatment of lower-limb spasticity in children and adolescents with cerebral palsy: A phase 3 study

Heinen F, Kanovský P, Schroeder AS, Chambers HG, Dabrowski E, Geister TL, Hanschmann A, Martinez-Torres FJ, Pulte I, Banach M, Gaebler-Spira D.

J Pediatr Rehabil Med. 2021;14(2):183-197. doi: 10.3233/PRM-210040.

Cortical somatosensory processing after botulinum toxin therapy in post-stroke spasticity

Veverka T, Hluštík P, Otruba P, Hok P, Opavský R, Zapletalová J, Kaňovský P.

Medicine (Baltimore). 2021 Jun 25;100(25):e26356. doi: 10.1097/MD.0000000000026356.

Genotype-Phenotype Relations for the Atypical Parkinsonism Genes: MDSGene Systematic Review

Wittke C, Petkovic S, Dobricic V, Schaake S; MDS‐endorsed PSP Study Group; Respondek G, Weissbach A, Madoev H, Trinh J, Vollstedt EJ, Kuhnke N, Lohmann K, Dulovic Mahlow M, Marras C, König IR, Stamelou M, Bonifati V, Lill CM, Kasten M, Huppertz HJ, Höglinger G, Klein C.

Mov Disord. 2021 Jul;36(7):1499-1510. doi: 10.1002/mds.28517. Epub 2021 Mar 19.

Assessment, goal setting, and botulinum neurotoxin a therapy in the management of post-stroke spastic movement disorder: updated perspectives on best practice

Wissel J, Ri S.

Expert Rev Neurother. 2022 Jan;22(1):27-42. doi: 10.1080/14737175.2021.2021072. Epub 2021 Dec 30.

Recent Advances in the Neural Control of Movements: Lessons for Functional Recovery

Latash ML, Yamagata M.

Phys Ther Res. 2021 Sep 29;25(1):1-11. doi: 10.1298/ptr.R0018. eCollection 2022.

Spinal cord stimulation: beyond pain management

Tapias Pérez JH.

Neurologia (Engl Ed). 2022 Sep;37(7):586-595. doi: 10.1016/j.nrleng.2019.05.007. Epub 2021 May 25.

Functional motor disorders associated with other neurological diseases: Beyond the boundaries of "organic" neurology

Tinazzi M, Geroin C, Erro R, Marcuzzo E, Cuoco S, Ceravolo R, Mazzucchi S, Pilotto A, Padovani A, Romito LM, Eleopra R, Zappia M, Nicoletti A, Dallocchio C, Arbasino C, Bono F, Pascarella A, Demartini B, Gambini O, Modugno N, Olivola E, Bonanni L, Antelmi E, Zanolin E, Albanese A, Ferrazzano G, de Micco R, Lopiano L, Calandra-Buonaura G, Petracca M, Esposito M, Pisani A, Manganotti P, Stocchi F, Coletti Moja M, Antonini A, Ercoli T, Morgante F.

Eur J Neurol. 2021 May;28(5):1752-1758. doi: 10.1111/ene.14674. Epub 2021 Jan 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias